Lichenoid lupus erythematosus / lichen planus (overlap syndrome) is a rare skin lesion in patients with systemic lupus erythematosus
https://doi.org/10.47360/1995-4484-2025-524-531
Abstract
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that affects many organs and is characterized by a complex interaction of immune cells, factors and pathways leading to various clinical manifestations. During the disease duration, skin involvement occurs in about 75–80% (up to 20–25% in the debut) of patients with SLE. This article describes two clinical cases with rare chronic skin involvement in patients with SLE.
About the Authors
P. A. Sholkina
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Competing Interests:
Russian Federation
Polina A. Sholkina
115522, Moscow, Kashirskoye Highway, 34A
Competing Interests:
None
A. A. Shumilova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Competing Interests:
Russian Federation
Anastasiia A. Shumilova
115522, Moscow, Kashirskoye Highway, 34A
Competing Interests:
None
E. I. Travkina
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Competing Interests:
Russian Federation
Ekaterina I. Travkina
115522, Moscow, Kashirskoye Highway, 34A
Competing Interests:
None
L. A. Semenova
V.A. Nasonova Research Institute of Rheumatology ; Central Research Institute of Tuberculosis
Russian Federation
Competing Interests:
Russian Federation
Lyudmila A. Semenova
115522, Moscow, Kashirskoye Highway, 34A
107564, Moscow, Yauzskaya Alley, 2, building 1A
Competing Interests:
None
T. M. Reshetnyak
V.A. Nasonova Research Institute of Rheumatology ; Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of the Russian Federation
Russian Federation
Competing Interests:
Russian Federation
Tatiana M. Reshetnyak
115522, Moscow, Kashirskoye Highway, 34A
125993, Moscow, Barrikadnaya str., 2/1, building 1
Competing Interests:
None
References
1. Nasonov EL (ed.). Rheumatology. Russian clinical recommendations. Moscow: GEOTAR-Media;2017 (In Russ.).
2. Nasonov EL, Soloviev SK, Arshinov AV. Systemic lupus erythematosus: History and modernity. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2022;60(4):397-412 (In Russ.). doi: 10.47360/1995-4484-2022-397-412
3. Stull C, Sprow G, Werth VP. Cutaneous involvement in systemic lupus erythematosus: A review for the rheumatologist. J Rheumatol. 2023;50(1):27-35. doi: 10.3899/jrheum.220089
4. Niebel D, de Vos L, Fetter T, Brägelmann C, Wenzel J. Cutaneous lupus erythematosus: An update on pathogenesis and future therapeutic directions. Am J Clin Dermatol. 2023;24(4):521-540. doi: 10.1007/s40257-023-00774-8
5. Shumilova АА, Cheldieva FA, Nurbaeva КS, Travkiva ЕI, Reshetnyak ТМ. Indexes of skin activity and damage in patients with systemic lupus erythematosus – CLASI and R-CLASI. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2024;62(2):203-215 (In Russ.). doi: 10.47360/1995-4484-2024-203-215
6. Gilliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol. 1981;4(4):471-475. doi: 10.1016/s0190-9622(81)80261-7
7. Shumilova AA, Travkina EI, Reshetnyak TM. Skin lesions in systemic lupus erythematosus. Part 1: Classification, etiology, pathogenesis. Modern Rheumatology Journal. 2022;16(3):7-13. (In Russ.). doi: 10.14412/1996-7012-2022-3-7-13
8. Shumilova AA, Travkina EI, Reshetnyak TM. Skin lesions in systemic lupus erythematosus. Part 2: Clinical and histological features. Modern Rheumatology Journal. 2022;16(4):7-14 (In Russ.). doi: 10.14412/1996-7012-2022-4-7-14
9. McParland H. Oral lichenoid and lichen planus-like lesions. Prim Dent J. 2016;5(1):34-39. doi: 10.1177/205016841600500103
10. Tziotzios C, Lee JYW, Brier T, Saito R, Hsu CK, Bhargava K, et al. Lichen planus and lichenoid dermatoses: Clinical overview and molecular basis. J Am Acad Dermatol. 2018;79(5):789-804. doi: 10.1016/j.jaad.2018.02.010
11. Nikolaeva MY, Monakhov KN, Sokolovskiy EV. Lichen planuslupus erythematosus overlap syndrome. Vestnik dermatologii i venerologii. 2022;98(2):63-72 (In Russ.). doi: 10.25208/vdv1296
12. Gru AA, Salavaggione AL. Lichenoid and interface dermatoses. Semin Diagn Pathol. 2017;34(3):237-249. doi: 10.1053/j.semdp.2017.03.001
13. Wang R, Zhang X, Wang S. Differential genotypes of TNF-α and IL-10 for immunological diagnosis in discoid lupus erythematosus and oral lichen planus: A narrative review. Front Immunol. 2022;13:967281. doi: 10.3389/fimmu.2022.967281
14. Rakhshan A, Toossi P, Amani M, Dadkhahfar S, Hamidi AB. Different distribution patterns of plasmacytoid dendritic cells in discoid lupus erythematosus and lichen planopilaris demonstrated by CD123 immunostaining. An Bras Dermatol. 2020;95(3):307- 313. doi: 10.1016/j.abd.2019.11.005
15. Gupta MK, Lipner SR. Review of nail lichen planus: Epidemiology, pathogenesis, diagnosis, and treatment. Dermatol Clin. 2021;39(2):221-230. doi: 10.1016/j.det.2020.12.002
16. Dorozhenok IY, Snarskaya ES, Mikhailova M. Lichen planus and itch-related psychosomatic disorders. Russian Journal of Skin and Venereal Diseases. 2021;24(6):543-551 (In Russ.). doi: 10.17816/dv100612
17. Tekin B, Xie F, Lehman JS. Lichen planus: What is new in diagnosis and treatment? Am J Clin Dermatol. 2024;25(5):735-764. doi: 10.1007/s40257-024-00878-9
18. Snarskaya ES, Proskurina MV, Bobrov MA, Molochkova YV. Clinical and morphologic features of the pigmented lichen planus. Russian Journal of Skin and Venereal Diseases. 2013;16(5):40-43 (In Russ.). doi: 10.17816/dv36850.
19. Rodionov AN (ed.) Clinical dermatology. Moscow:GEOTAR-Media;2019 (In Russ.).
20. Kusari A, Ahluwalia J. Lichen planus. N Engl J Med. 2018;379(6):567. doi: 10.1056/NEJMicm1802078
21. Fedotova KIu, Zhukova OV, Kruglova LS, Ptashinskiĭ RI. Lichen ruber planus: Etiology, pathogenesis, clinical entities, histological pattern and the main treatment principles. Russian Journal of Clinical Dermatology and Venereology. 2014;12(6):9-20 (In Russ.). doi: 10.17116/klinderma201469-19
22. Solimani F, Forchhammer S, Schloegl A, Ghoreschi K, Meier K. Lichen planus – a clinical guide. J Dtsch Dermatol Ges. 2021;19(6):864-882. doi: 10.1111/ddg.14565
23. Louisy A, Humbert E, Samimi M. Oral lichen planus: An update on diagnosis and management. Am J Clin Dermatol. 2024;25(1):35- 53. doi: 10.1007/s40257-023-00814-3
24. Nogueira PA, Carneiro S, Ramos-e-Silva M. Oral lichen planus: An update on its pathogenesis. Int J Dermatol. 2015;54(9):1005- 1010. doi: 10.1111/ijd.12918
25. McDermott E, Solomon N, Silva AM, Khoshpouri P. Lichen planus. Radiographics. 2023;43(4):e220200. doi: 10.1148/rg.220200
26. Nosratzehi T. Oral lichen planus: An overview of potential risk factors, biomarkers and treatments. Asian Pac J Cancer Prev. 2018;19(5):1161-1167. doi: 10.22034/APJCP.2018.19.5.1161
27. McGrath H Jr. Ultraviolet-A1 irradiation therapy for systemic lupus erythematosus. Lupus. 2017;26(12):1239-1251. doi: 10.1177/0961203317707064
28. Wang PW, Hung YC, Lin TY, Fang JY, Yang PM, Chen MH, et al. Comparison of the biological impact of UVA and UVB upon the skin with functional proteomics and immunohistochemistry. Antioxidants (Basel). 2019;8(12):569. doi: 10.3390/antiox8120569
29. Menke J, Hsu MY, Byrne KT, Lucas JA, Rabacal WA, Croker BP, et al. Sunlight triggers cutaneous lupus through a CSF-1-dependent mechanism in MRL-Fas(lpr) mice. J Immunol. 2008;181(10):7367-7379. doi: 10.4049/jimmunol.181.10.7367
30. Oke V, Vassilaki I, Espinosa A, Strandberg L, Kuchroo VK, Nyberg F, et al. High Ro52 expression in spontaneous and UVinduced cutaneous inflammation. J Invest Dermatol. 2009;129(8):2000-2010. doi: 10.1038/jid.2008.453
31. Salah E. Clinical and dermoscopic spectrum of discoid lupus erythematosus: Novel observations from lips and oral mucosa. Int J Dermatol. 2018;57(7):830-836. doi: 10.1111/ijd.14015
32. Żychowska M, Reich A. Chronic cutaneous lupus erythematosus in a white population: Dermoscopic characteristics by clinical subtype, lesion location and disease duration. Dermatol Ther (Heidelb). 2022;12(9):2117-2133. doi: 10.1007/s13555-022-00786-y
33. Andreadis D, Pavlou A, Vakirlis E, Anagnostou E, Vrani F, Poulopoulos A, et al. Actinic cheilitis may resemble oral lichenoid-type lesions or discoid lupus erythematosus. Arch Dermatol Res. 2021;313(10):891-892. doi: 10.1007/s00403-021-02194-2
34. Sarkar MK, Hile GA, Tsoi LC, Xing X, Liu J, Liang Y, et al. Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa. Ann Rheum Dis. 2018;77(11):1653-1664. doi: 10.1136/annrheumdis-2018-213197
35. Loncharich MF, Robertson I. Anifrolumab in systemic lupus erythematosus. Drugs Today (Barc). 2023;59(2):53-61. doi: 10.1358/dot.2023.59.2.3521876
36. Chatham WW, Furie R, Saxena A, Brohawn P, Schwetje E, Abreu G, et al. Long-term safety and efficacy of anifrolumab in adults with systemic lupus erythematosus: Results of a phase II open-label extension study. Arthritis Rheumatol. 2021;73(5):816- 825. doi: 10.1002/art.41598
37. Furie RA, Morand EF, Bruce IN, Manzi S, Kalunian KC, Vital EM, et al.; TULIP-1 Study Investigators. Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): A randomised, controlled, phase 3 trial. Lancet Rheumatol. 2019;1(4):e208-e219. doi: 10.1016/S2665-9913(19)30076-1
38. Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, et al.; TULIP-2 Trial Investigators. Trial of anifrolumab in active systemic lupus erythematosus. N Engl J Med. 2020;382(3):211-221. doi: 10.1056/NEJMoa1912196
39. Reshetnyak TM, Aseeva EA, Shumilova AA, Nikishina NY, Shkireeva SY, Lila AM. Portrait of a patient with systemic lupus erythematosus for the prescription of the type I interferon inhibitor anifrolumab. Modern Rheumatology Journal. 2023;17(6):14-21 (In Russ.). doi: 10.14412/1996-7012-2023-6-14-21
Review
For citations:
Sholkina P.A., Shumilova A.A., Travkina E.I., Semenova L.A., Reshetnyak T.M. Lichenoid lupus erythematosus / lichen planus (overlap syndrome) is a rare skin lesion in patients with systemic lupus erythematosus. Rheumatology Science and Practice. 2025;63(5):524-531. (In Russ.) https://doi.org/10.47360/1995-4484-2025-524-531
Views:
6
Email this article 